Cargando…
Drug Discovery for Schistosomiasis: Hit and Lead Compounds Identified in a Library of Known Drugs by Medium-Throughput Phenotypic Screening
BACKGROUND: Praziquantel (PZQ) is the only widely available drug to treat schistosomiasis. Given the potential for drug resistance, it is prudent to search for novel therapeutics. Identification of anti-schistosomal chemicals has traditionally relied on phenotypic (whole organism) screening with adu...
Autores principales: | Abdulla, Maha-Hamadien, Ruelas, Debbie S., Wolff, Brian, Snedecor, June, Lim, Kee-Chong, Xu, Fengyun, Renslo, Adam R., Williams, Janice, McKerrow, James H., Caffrey, Conor R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702839/ https://www.ncbi.nlm.nih.gov/pubmed/19597541 http://dx.doi.org/10.1371/journal.pntd.0000478 |
Ejemplares similares
-
Schistosomiasis Mansoni: Novel Chemotherapy Using a Cysteine Protease Inhibitor
por: Abdulla, Maha-Hamadien, et al.
Publicado: (2007) -
Proteomic Identification of IPSE/alpha-1 as a Major Hepatotoxin Secreted by Schistosoma mansoni Eggs
por: Abdulla, Maha-Hamadien, et al.
Publicado: (2011) -
World Class Parasites: Vol. X, Schistosomiasis
por: McKerrow, James
Publicado: (2006) -
A Global Comparison of the Human and T. brucei Degradomes Gives Insights about Possible Parasite Drug Targets
por: Mashiyama, Susan T., et al.
Publicado: (2012) -
Mining a Cathepsin Inhibitor Library for New Antiparasitic Drug Leads
por: Ang, Kenny K. H., et al.
Publicado: (2011)